Mirum Pharmaceuticals, Inc.
METHODS FOR TREATING CHOLESTASIS
Last updated:
Abstract:
Provided herein are methods for treating cholestasis in a subject having a liver disease. The method includes administering to the subject an Apical Sodium-dependent Bile Acid Transporter (ASBTI). More specifically, the present invention relates to methods for treating cholestasis in a subject where the method includes administering an ASBTI to a subject at a dose of at least 10 .mu.g/kg/day.
Status:
Application
Type:
Utility
Filling date:
14 Aug 2020
Issue date:
3 Dec 2020